Details
Join us live to explore how ATTR-CM treatment success can be measured in clinical practice.
Register here: https://ow.ly/XM8w50ZjBVX
This CME-accredited webinar will examine worsening heart failure, clinical stability, clinical improvement and disease-modifying treatment outcomes in transthyretin amyloid cardiomyopathy.
Broadcasting: Tuesday 07 July 2026 | 17:30 CEST
This programme is sponsored by an unrestricted educational grant from Bayer.